CD24 negative lung cancer cells, possessing partial cancer stem cell properties, cannot be considered as cancer stem cells.
Ontology highlight
ABSTRACT: Cancer stem cells (CSCs) play vital role in lung cancer progression, resistance, metastasis and relapse. Identifying lung CSCs makers for lung CSCs targeting researches are critical for lung cancer therapy. In this study, utilizing previous identified lung CSCs as model, we compared the expression of CD24, CD133 and CD44 between CSCs and non-stem cancer cells. Increased ratio of CD24- cells were found in CSCs. CD24- cells were then sorted by flow cytometry and their proliferative ability, chemo-resistance property and in vivo tumor formation abilities were detected. A549 CD24- cells formed smaller colonies, slower proliferated in comparison to A549 CD24+ cells. Besides, A549 CD24- exhibited stronger resistance to chemotherapy drug. However, A549 CD24- didn't exert any stronger tumor format
SUBMITTER: Xu H
PROVIDER: S-EPMC4759396 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature
ACCESS DATA